Search Results - Liang, Xiong-An

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study by Qin, Shukui, Chan, Stephen L, Bai, Yuxian, Chen, Zhendong, Jia, Weidong, Jin, Yongdong, Guo, Yabing, Hu, Xiaohua, Meng, Zhiqiang, Liang, Jun, Cheng, Ying, Xiong, Jianping, Ren, Hong, Chen, Yajin, Zeng, Yong, Sultanbaev, Alexander, Pazgan-Simon, Monika, Melisi, Davide, Ponomarenko, Dmitriy, Sinielnikov, Ivan, Yang, Tsai-Sheng, Liang, Xiao, Chen, Chunxia, Wang, Linna, Cheng, Ann-Lii, Vogel, Arndt, Qin, Shukui, Chan, Stephen L, Vogel, Arndt, Gu, Shanzhi, Bai, Yuxian, Ren, Zhenggang, Lin, Xiaoyan, Chen, Zhendong, Hu, Xiaohua, Meng, Zhiqiang, Liang, Jun, Cheng, Ying, Xiong, Jianping, Ren, Hong, Yang, Fang, Zeng, Yong, Sultanbaev, Alexander, Pisetska, Margaryta, Melisi, Davide, Ponomarenko, Dmitriy, Osypchuk, Yurii, Sinielnikov, Ivan, Yang, Tsai-Sheng, Liang, Xiao, Chen, Chunxia, Zhang, Mingxiang, Xu, Li, Li, Da, Ying, Jierer, Zhang, Jingdong, Zhang, Tao, He, Yifu, Jiang, Da, Xing, Baocai, Zhang, Baihong, Wang, Dong, Zhai, Xiaofeng, Liang, Houjie, Cybulska-Stopa, Bozena, Dvorkin, Mikhail, Stroyakovskiy, Daniil, Yen, Chia-Jui, Su, Wei-Wen, Chen, Yen-Hao, Bondarenko, Igor, Fang, Weijia, Gomez-Martin, Carlos, Ryu, Min-Hee, Kim, Han-Sang, Kim, Jee-Hyun, Orlova, Rashida, Fadeeva, Natalia, Makarova, Yulia, Hung, Chao-Hung, Neffa, Maryna, Vynnychenko, Oleksandr, Burgoyne, Adam, Hao, Chunyi, Mohr, Raphael U, Diaz-Beveridge, Roberto, Feliu-Batlle, Jaime, Antonuzzo, Lorenzo, Scartozzi, Mario, Ahn, Mi Sun, Oh, Sung-Yong, Orlov, Sergey, Oksuzoglu, Berna, Rau, Kun-Ming, Krechkovskyi, Oleksandr, Yareshko, Vladimir, Xiong, Henry, Lee, Fa-Chyi, Jiang, Yixing, Verset, Gontran

    Get full text
    Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial by Dai, Qiliang, Ye, Ruidong, Zi, Wenjie, Wang, Huaiming, Ma, Minmin, Yin, Qin, Fan, Xinying, Lv, Qiushi, Yang, Dong, Shi, Zhonghua, Zheng, Dequan, Wan, Yue, Wang, Zhen, Geng, Yu, Chen, Xingyu, Liao, Geng, Liu, Yumin, Liu, Xintong, Zhang, Meng, Zhou, Feng, Shi, Hongchao, Zhang, Yunfeng, Guo, Fuqiang, Yin, Congguo, Niu, Guozhong, Zhang, Mei, Cai, Xueli, Zhu, Qiyi, Liang, Yingchun, Li, Bing, Lin, Min, Wang, Wei, Xu, Haowen, Tian, Xiguang, Gong, Zili, Shi, Haicun, Wang, Chuanming, Lv, Penghua, Tao, Zhonghai, Zhu, Liangfu, Yang, Shiquan, Hu, Wei, Pereira, Vitor M, Leung, Thomas, Davis, Stephen, Xu, Gelin, Nogueira, Raul G, Liu, Xinfeng, Xu, Gelin, Zhu, Wusheng, Xiong, Yunyun, Liu, Yuxiu, Zheng, Dequan, Deng, Xiaorong, Wan, Yue, Wang, Zhen, Geng, Yu, Shi, Zongjie, Zheng, Weihong, Chen, Xingyu, Zhou, Zhiming, Huang, Xianjun, Jin, Ping, Li, Huagang, Liu, Xintong, Zhang, Meng, Zhou, Feng, Shi, Hongchao, Ke, Kaifu, Zhang, Yunfeng, Guo, Fuqiang, Yang, Shu, Yin, Congguo, Niu, Guozhong, Zhang, Mei, Cai, Xueli, Zhu, Qiyi, Chen, Zhonglun, Liang, Yingchun, Lin, Min, Lin, Hang, Wang, Wei, Xu, Haowen, Fu, Xinmin, Dan, Wei, Tian, Xiguang, Shi, Haicun, Wang, Chuanming, Lv, Penghua, Tao, Zhonghai, Rong, Liangqun, Wang, Shuiping, Yang, Shiquan, Jiang, Pingzhou, Fan, Jin, Wang, Changqing, Li, Xiaobo, Pereira, Vitor, Yan, Bernard, Liebeskind, David

    Published in Lancet neurology
    Get full text
    Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20